The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein

Chemistry : a European Journal
Therese BuskasGeert-Jan Boons

Abstract

A Lewis(y) (Le(y)) tetrasaccharide modified by an artificial aminopropyl spacer was synthesized by a highly convergent approach that employed a levulinoyl ester and a 9-fluorenylmethoxycarbonate for temporary protection of the hydroxy groups and a trichloroethyloxycarbonyl as an amino protecting group. The artificial aminopropyl moiety was modified by a thioacetyl group, which allowed efficient conjugation to keyhole limpet hemocyanin (KLH) modified by electrophilic 4-(maleimidomethyl)cyclohexane-1-carboxylate (MI). Mice were immunized with the KLH-MI-Le(y) antigen. A detailed analysis of sera by ELISA established that a strong immunoglobulin G (IgG) antibody response was elicited against the linker region. The use of a smaller and more flexible 3-(bromoacetamido)propionate for the attachment of Le(y) to KLH not only reduced the IgG antibody response against the linker but also led to a significantly improved immune response against the Le(y) antigen. This study shows that highly antigenic linkers suppress antibody responses to weak antigens such as self-antigens.

Citations

May 6, 2011·Glycoconjugate Journal·Tomasz LipinskiDavid R Bundle
Jun 7, 2012·Glycoconjugate Journal·Chang-Cheng Liu, Xin-Shan Ye
Sep 4, 2007·Nature Chemical Biology·Sampat IngaleGeert-Jan Boons
Apr 2, 2010·Nature Reviews. Drug Discovery·Rena D Astronomo, Dennis R Burton
Sep 3, 2009·Chemical Communications : Chem Comm·Therese BuskasGeert-Jan Boons
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hong XinJim E Cutler
Dec 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Vani LakshminarayananGeert-Jan Boons
Oct 13, 2007·Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections·R N StepanenkoR V Petrov
Sep 15, 2016·ACS Infectious Diseases·Guochao LiaoZhongwu Guo
Jun 1, 2012·Expert Opinion on Drug Discovery·Paolo CostantinoFrancesco Berti
Feb 20, 2016·ACS Chemical Biology·Danyang FengFengshan Wang
Feb 24, 2016·Journal of Immunology Research·Adi Essam ZareiElrashdy M Redwan
May 2, 2012·International Journal of Pharmaceutics·Wei WangSandeep Nema
Oct 4, 2011·Vaccine·Jamie Heimburg-MolinaroKate Rittenhouse-Olson
Mar 5, 2016·Human Vaccines & Immunotherapeutics·Michael BrökerPaolo Costantino
Jul 23, 2015·ACS Applied Materials & Interfaces·Suttipun SungsuwanXuefei Huang
Dec 20, 2012·Chemical Society Reviews·Francesco Peri
Jul 30, 2016·Vaccines·Md Kamal Hossain, Katherine A Wall
Aug 6, 2016·Pharmacology & Therapeutics·Rémy Gébleux, Giulio Casi
Sep 22, 2009·Current Opinion in Chemical Biology·Zhongwu Guo, Qianli Wang
Feb 5, 2016·Scientific Reports·Uwe MögingerDaniel Kolarich
Mar 16, 2017·Chemistry : a European Journal·Ting-Chun KuanChun-Cheng Lin
Nov 28, 2006·Carbohydrate Research·Aileen F G Bongat, Alexei V Demchenko
May 15, 2015·Chemical Communications : Chem Comm·Guochao LiaoZhongwu Guo
Mar 8, 2018·Medicinal Research Reviews·Meng-Man WeiXin-Shan Ye
Mar 10, 2016·Organic & Biomolecular Chemistry·Kevin R TrabbicPeter R Andreana
Dec 1, 2011·Angewandte Chemie·Che-Hsiung HsuChi-Huey Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.